Tag: Aducanumab

Biotechnology Investing News Market News Technology

Biogen Rises over 35% on Plans to Pursue FDA Approval

Bryan Shin10/22/2019

3962

Biogen Inc. (NASDAQ: BIIB) shares surged by over 35% on Tuesday morning after the Company announced it will seek U.S. FDA approval for its Alzheimer’s drug, aducanumab. Aducanumab is...

Biotechnology Healthcare Investing News Market News Technology

Biogen Shares Crater after Scrapping Alzheimer’s Drug

financial buzz03/21/2019

6979

Biogen Inc. (NASDAQ: BIIB) shares cratered on Thursday morning after the Company decided to terminate its Phase 3 and future clinical trials for its Alzheimer’s disease drug. Biogen shares...

Tag: Aducanumab

Biogen Rises over 35% on Plans to Pursue FDA Approval

Biogen Shares Crater after Scrapping Alzheimer’s Drug

ABOUT US

Tweets